Quince Therapeutics to participate in September 2026 investor conferences
Quince Therapeutics said senior management will participate in September 2026 investor conferences, according to the company’s announcement.
SOUTH SAN FRANCISCO, Calif., Sept.
03, 2026 (GLOBE NEWSWIRE) -- Quince Therapeutics, Inc.
NASDAQ:QNCX, a clinical stage biopharmaceutical company focused on the development of novel, disease modifying therapies for serious underserved diseases, today announced that senior management will participat…